nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—BCHE—Triamcinolone—psoriatic arthritis	0.416	0.455	CbGbCtD
Neostigmine—ABCB1—Methylprednisolone—psoriatic arthritis	0.139	0.152	CbGbCtD
Neostigmine—ABCB1—Betamethasone—psoriatic arthritis	0.0907	0.099	CbGbCtD
Neostigmine—ABCB1—Prednisolone—psoriatic arthritis	0.0895	0.0977	CbGbCtD
Neostigmine—ABCB1—Prednisone—psoriatic arthritis	0.0845	0.0923	CbGbCtD
Neostigmine—ABCB1—Dexamethasone—psoriatic arthritis	0.0527	0.0576	CbGbCtD
Neostigmine—ABCB1—Methotrexate—psoriatic arthritis	0.0424	0.0463	CbGbCtD
Neostigmine—Abnormal behaviour—Methylprednisolone—psoriatic arthritis	0.00278	0.033	CcSEcCtD
Neostigmine—Flatulence—Auranofin—psoriatic arthritis	0.00153	0.0181	CcSEcCtD
Neostigmine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00103	0.0123	CcSEcCtD
Neostigmine—Wheezing—Triamcinolone—psoriatic arthritis	0.00101	0.012	CcSEcCtD
Neostigmine—Urticaria—Auranofin—psoriatic arthritis	0.00101	0.0119	CcSEcCtD
Neostigmine—Abdominal pain—Auranofin—psoriatic arthritis	0.001	0.0118	CcSEcCtD
Neostigmine—Paralysis—Methotrexate—psoriatic arthritis	0.000988	0.0117	CcSEcCtD
Neostigmine—Pruritus—Auranofin—psoriatic arthritis	0.000895	0.0106	CcSEcCtD
Neostigmine—Diarrhoea—Auranofin—psoriatic arthritis	0.000866	0.0103	CcSEcCtD
Neostigmine—Osteoarthritis—Prednisolone—psoriatic arthritis	0.000821	0.00972	CcSEcCtD
Neostigmine—Vomiting—Auranofin—psoriatic arthritis	0.000804	0.00953	CcSEcCtD
Neostigmine—Rash—Auranofin—psoriatic arthritis	0.000798	0.00945	CcSEcCtD
Neostigmine—Dermatitis—Auranofin—psoriatic arthritis	0.000797	0.00944	CcSEcCtD
Neostigmine—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00078	0.00924	CcSEcCtD
Neostigmine—Osteoarthritis—Triamcinolone—psoriatic arthritis	0.000755	0.00894	CcSEcCtD
Neostigmine—Osteoarthritis—Methylprednisolone—psoriatic arthritis	0.000753	0.00892	CcSEcCtD
Neostigmine—Nausea—Auranofin—psoriatic arthritis	0.000751	0.0089	CcSEcCtD
Neostigmine—Dysarthria—Methotrexate—psoriatic arthritis	0.000726	0.0086	CcSEcCtD
Neostigmine—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.000718	0.0085	CcSEcCtD
Neostigmine—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.000716	0.00848	CcSEcCtD
Neostigmine—Sweating increased—Prednisolone—psoriatic arthritis	0.000691	0.00818	CcSEcCtD
Neostigmine—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.000685	0.00811	CcSEcCtD
Neostigmine—Osteoarthritis—Betamethasone—psoriatic arthritis	0.000685	0.00811	CcSEcCtD
Neostigmine—Cardiac arrest—Betamethasone—psoriatic arthritis	0.000651	0.00771	CcSEcCtD
Neostigmine—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.000651	0.00771	CcSEcCtD
Neostigmine—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00064	0.00758	CcSEcCtD
Neostigmine—Sweating increased—Triamcinolone—psoriatic arthritis	0.000635	0.00753	CcSEcCtD
Neostigmine—Sweating increased—Methylprednisolone—psoriatic arthritis	0.000634	0.00751	CcSEcCtD
Neostigmine—Coma—Methotrexate—psoriatic arthritis	0.000627	0.00743	CcSEcCtD
Neostigmine—Osteoarthritis—Prednisone—psoriatic arthritis	0.000596	0.00706	CcSEcCtD
Neostigmine—Bradycardia—Prednisolone—psoriatic arthritis	0.000578	0.00685	CcSEcCtD
Neostigmine—Sweating increased—Dexamethasone—psoriatic arthritis	0.000577	0.00683	CcSEcCtD
Neostigmine—Sweating increased—Betamethasone—psoriatic arthritis	0.000577	0.00683	CcSEcCtD
Neostigmine—Cardiac arrest—Prednisone—psoriatic arthritis	0.000567	0.00672	CcSEcCtD
Neostigmine—Bradycardia—Triamcinolone—psoriatic arthritis	0.000532	0.0063	CcSEcCtD
Neostigmine—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00053	0.00628	CcSEcCtD
Neostigmine—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000512	0.00606	CcSEcCtD
Neostigmine—Arrhythmia—Prednisolone—psoriatic arthritis	0.000507	0.00601	CcSEcCtD
Neostigmine—Sweating increased—Prednisone—psoriatic arthritis	0.000502	0.00595	CcSEcCtD
Neostigmine—Osteoarthritis—Methotrexate—psoriatic arthritis	0.000498	0.0059	CcSEcCtD
Neostigmine—Bradycardia—Dexamethasone—psoriatic arthritis	0.000482	0.00571	CcSEcCtD
Neostigmine—Bradycardia—Betamethasone—psoriatic arthritis	0.000482	0.00571	CcSEcCtD
Neostigmine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00047	0.00556	CcSEcCtD
Neostigmine—Arrhythmia—Triamcinolone—psoriatic arthritis	0.000466	0.00553	CcSEcCtD
Neostigmine—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.000465	0.00551	CcSEcCtD
Neostigmine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000456	0.00541	CcSEcCtD
Neostigmine—Syncope—Prednisolone—psoriatic arthritis	0.000443	0.00525	CcSEcCtD
Neostigmine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000434	0.00515	CcSEcCtD
Neostigmine—Convulsion—Prednisolone—psoriatic arthritis	0.000428	0.00507	CcSEcCtD
Neostigmine—Arrhythmia—Betamethasone—psoriatic arthritis	0.000423	0.00501	CcSEcCtD
Neostigmine—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000423	0.00501	CcSEcCtD
Neostigmine—Bradycardia—Prednisone—psoriatic arthritis	0.00042	0.00498	CcSEcCtD
Neostigmine—Syncope—Triamcinolone—psoriatic arthritis	0.000408	0.00483	CcSEcCtD
Neostigmine—Syncope—Methylprednisolone—psoriatic arthritis	0.000407	0.00482	CcSEcCtD
Neostigmine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000405	0.0048	CcSEcCtD
Neostigmine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000403	0.00478	CcSEcCtD
Neostigmine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000399	0.00473	CcSEcCtD
Neostigmine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000399	0.00472	CcSEcCtD
Neostigmine—Shock—Prednisolone—psoriatic arthritis	0.000397	0.0047	CcSEcCtD
Neostigmine—Convulsion—Triamcinolone—psoriatic arthritis	0.000394	0.00466	CcSEcCtD
Neostigmine—Tachycardia—Prednisolone—psoriatic arthritis	0.000394	0.00466	CcSEcCtD
Neostigmine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000393	0.00465	CcSEcCtD
Neostigmine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00039	0.00462	CcSEcCtD
Neostigmine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000386	0.00457	CcSEcCtD
Neostigmine—Drowsiness—Methotrexate—psoriatic arthritis	0.000384	0.00455	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000383	0.00454	CcSEcCtD
Neostigmine—Flushing—Prednisone—psoriatic arthritis	0.000383	0.00454	CcSEcCtD
Neostigmine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000378	0.00448	CcSEcCtD
Neostigmine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000371	0.00439	CcSEcCtD
Neostigmine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00037	0.00438	CcSEcCtD
Neostigmine—Syncope—Betamethasone—psoriatic arthritis	0.00037	0.00438	CcSEcCtD
Neostigmine—Syncope—Dexamethasone—psoriatic arthritis	0.00037	0.00438	CcSEcCtD
Neostigmine—Arrhythmia—Prednisone—psoriatic arthritis	0.000369	0.00437	CcSEcCtD
Neostigmine—Shock—Triamcinolone—psoriatic arthritis	0.000365	0.00432	CcSEcCtD
Neostigmine—Insomnia—Prednisolone—psoriatic arthritis	0.000365	0.00432	CcSEcCtD
Neostigmine—Shock—Methylprednisolone—psoriatic arthritis	0.000364	0.00431	CcSEcCtD
Neostigmine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000363	0.0043	CcSEcCtD
Neostigmine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000362	0.00429	CcSEcCtD
Neostigmine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000362	0.00429	CcSEcCtD
Neostigmine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000362	0.00429	CcSEcCtD
Neostigmine—Mental disorder—Prednisone—psoriatic arthritis	0.000361	0.00428	CcSEcCtD
Neostigmine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000361	0.00428	CcSEcCtD
Neostigmine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00036	0.00426	CcSEcCtD
Neostigmine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000359	0.00425	CcSEcCtD
Neostigmine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000358	0.00424	CcSEcCtD
Neostigmine—Convulsion—Betamethasone—psoriatic arthritis	0.000357	0.00423	CcSEcCtD
Neostigmine—Convulsion—Dexamethasone—psoriatic arthritis	0.000357	0.00423	CcSEcCtD
Neostigmine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000346	0.0041	CcSEcCtD
Neostigmine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000341	0.00403	CcSEcCtD
Neostigmine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000338	0.004	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000338	0.004	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000337	0.00399	CcSEcCtD
Neostigmine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000337	0.00399	CcSEcCtD
Neostigmine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000337	0.00399	CcSEcCtD
Neostigmine—Insomnia—Triamcinolone—psoriatic arthritis	0.000336	0.00397	CcSEcCtD
Neostigmine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000335	0.00397	CcSEcCtD
Neostigmine—Shock—Dexamethasone—psoriatic arthritis	0.000331	0.00392	CcSEcCtD
Neostigmine—Shock—Betamethasone—psoriatic arthritis	0.000331	0.00392	CcSEcCtD
Neostigmine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000331	0.00392	CcSEcCtD
Neostigmine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00033	0.00391	CcSEcCtD
Neostigmine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00033	0.00391	CcSEcCtD
Neostigmine—Agitation—Prednisone—psoriatic arthritis	0.00033	0.00391	CcSEcCtD
Neostigmine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000328	0.00389	CcSEcCtD
Neostigmine—Tachycardia—Betamethasone—psoriatic arthritis	0.000328	0.00389	CcSEcCtD
Neostigmine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000325	0.00385	CcSEcCtD
Neostigmine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000325	0.00385	CcSEcCtD
Neostigmine—Syncope—Prednisone—psoriatic arthritis	0.000322	0.00382	CcSEcCtD
Neostigmine—Urticaria—Prednisolone—psoriatic arthritis	0.00032	0.0038	CcSEcCtD
Neostigmine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000316	0.00374	CcSEcCtD
Neostigmine—Hypotension—Dexamethasone—psoriatic arthritis	0.000315	0.00373	CcSEcCtD
Neostigmine—Hypotension—Betamethasone—psoriatic arthritis	0.000315	0.00373	CcSEcCtD
Neostigmine—Convulsion—Prednisone—psoriatic arthritis	0.000311	0.00369	CcSEcCtD
Neostigmine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000311	0.00368	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000307	0.00363	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000307	0.00363	CcSEcCtD
Neostigmine—Arthralgia—Prednisone—psoriatic arthritis	0.000306	0.00362	CcSEcCtD
Neostigmine—Insomnia—Dexamethasone—psoriatic arthritis	0.000304	0.00361	CcSEcCtD
Neostigmine—Insomnia—Betamethasone—psoriatic arthritis	0.000304	0.00361	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000304	0.0036	CcSEcCtD
Neostigmine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000303	0.00359	CcSEcCtD
Neostigmine—Mental disorder—Methotrexate—psoriatic arthritis	0.000302	0.00358	CcSEcCtD
Neostigmine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000297	0.00352	CcSEcCtD
Neostigmine—Urticaria—Triamcinolone—psoriatic arthritis	0.000295	0.00349	CcSEcCtD
Neostigmine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000294	0.00348	CcSEcCtD
Neostigmine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000293	0.00347	CcSEcCtD
Neostigmine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000293	0.00347	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000291	0.00344	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000291	0.00344	CcSEcCtD
Neostigmine—Shock—Prednisone—psoriatic arthritis	0.000288	0.00342	CcSEcCtD
Neostigmine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000287	0.00341	CcSEcCtD
Neostigmine—Tachycardia—Prednisone—psoriatic arthritis	0.000286	0.00339	CcSEcCtD
Neostigmine—Skin disorder—Prednisone—psoriatic arthritis	0.000285	0.00337	CcSEcCtD
Neostigmine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000283	0.00336	CcSEcCtD
Neostigmine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000275	0.00326	CcSEcCtD
Neostigmine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000275	0.00326	CcSEcCtD
Neostigmine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000273	0.00324	CcSEcCtD
Neostigmine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000273	0.00323	CcSEcCtD
Neostigmine—Urticaria—Betamethasone—psoriatic arthritis	0.000267	0.00317	CcSEcCtD
Neostigmine—Urticaria—Dexamethasone—psoriatic arthritis	0.000267	0.00317	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000267	0.00316	CcSEcCtD
Neostigmine—Dizziness—Prednisolone—psoriatic arthritis	0.000267	0.00316	CcSEcCtD
Neostigmine—Asthenia—Triamcinolone—psoriatic arthritis	0.000266	0.00315	CcSEcCtD
Neostigmine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000266	0.00315	CcSEcCtD
Neostigmine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000266	0.00315	CcSEcCtD
Neostigmine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000266	0.00315	CcSEcCtD
Neostigmine—Insomnia—Prednisone—psoriatic arthritis	0.000265	0.00314	CcSEcCtD
Neostigmine—Pruritus—Triamcinolone—psoriatic arthritis	0.000262	0.00311	CcSEcCtD
Neostigmine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000262	0.0031	CcSEcCtD
Neostigmine—Convulsion—Methotrexate—psoriatic arthritis	0.00026	0.00308	CcSEcCtD
Neostigmine—Arthralgia—Methotrexate—psoriatic arthritis	0.000256	0.00303	CcSEcCtD
Neostigmine—Rash—Prednisolone—psoriatic arthritis	0.000254	0.00301	CcSEcCtD
Neostigmine—Dermatitis—Prednisolone—psoriatic arthritis	0.000254	0.00301	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000254	0.00301	CcSEcCtD
Neostigmine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000253	0.003	CcSEcCtD
Neostigmine—Headache—Prednisolone—psoriatic arthritis	0.000253	0.00299	CcSEcCtD
Neostigmine—Dizziness—Triamcinolone—psoriatic arthritis	0.000245	0.00291	CcSEcCtD
Neostigmine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000245	0.0029	CcSEcCtD
Neostigmine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000245	0.0029	CcSEcCtD
Neostigmine—Asthenia—Dexamethasone—psoriatic arthritis	0.000241	0.00286	CcSEcCtD
Neostigmine—Asthenia—Betamethasone—psoriatic arthritis	0.000241	0.00286	CcSEcCtD
Neostigmine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00024	0.00285	CcSEcCtD
Neostigmine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00024	0.00284	CcSEcCtD
Neostigmine—Nausea—Prednisolone—psoriatic arthritis	0.00024	0.00284	CcSEcCtD
Neostigmine—Pruritus—Betamethasone—psoriatic arthritis	0.000238	0.00282	CcSEcCtD
Neostigmine—Pruritus—Dexamethasone—psoriatic arthritis	0.000238	0.00282	CcSEcCtD
Neostigmine—Skin disorder—Methotrexate—psoriatic arthritis	0.000238	0.00282	CcSEcCtD
Neostigmine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000237	0.00281	CcSEcCtD
Neostigmine—Vomiting—Triamcinolone—psoriatic arthritis	0.000236	0.00279	CcSEcCtD
Neostigmine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000235	0.00279	CcSEcCtD
Neostigmine—Rash—Triamcinolone—psoriatic arthritis	0.000234	0.00277	CcSEcCtD
Neostigmine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000234	0.00277	CcSEcCtD
Neostigmine—Rash—Methylprednisolone—psoriatic arthritis	0.000233	0.00276	CcSEcCtD
Neostigmine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000233	0.00276	CcSEcCtD
Neostigmine—Urticaria—Prednisone—psoriatic arthritis	0.000233	0.00276	CcSEcCtD
Neostigmine—Headache—Triamcinolone—psoriatic arthritis	0.000232	0.00275	CcSEcCtD
Neostigmine—Headache—Methylprednisolone—psoriatic arthritis	0.000232	0.00275	CcSEcCtD
Neostigmine—Abdominal pain—Prednisone—psoriatic arthritis	0.000232	0.00274	CcSEcCtD
Neostigmine—Diarrhoea—Betamethasone—psoriatic arthritis	0.00023	0.00273	CcSEcCtD
Neostigmine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00023	0.00273	CcSEcCtD
Neostigmine—Hypotension—Methotrexate—psoriatic arthritis	0.000229	0.00271	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000223	0.00264	CcSEcCtD
Neostigmine—Dizziness—Dexamethasone—psoriatic arthritis	0.000223	0.00264	CcSEcCtD
Neostigmine—Dizziness—Betamethasone—psoriatic arthritis	0.000223	0.00264	CcSEcCtD
Neostigmine—Insomnia—Methotrexate—psoriatic arthritis	0.000222	0.00262	CcSEcCtD
Neostigmine—Nausea—Triamcinolone—psoriatic arthritis	0.00022	0.00261	CcSEcCtD
Neostigmine—Nausea—Methylprednisolone—psoriatic arthritis	0.00022	0.0026	CcSEcCtD
Neostigmine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000218	0.00259	CcSEcCtD
Neostigmine—Somnolence—Methotrexate—psoriatic arthritis	0.000218	0.00258	CcSEcCtD
Neostigmine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000216	0.00256	CcSEcCtD
Neostigmine—Vomiting—Dexamethasone—psoriatic arthritis	0.000214	0.00254	CcSEcCtD
Neostigmine—Vomiting—Betamethasone—psoriatic arthritis	0.000214	0.00254	CcSEcCtD
Neostigmine—Rash—Dexamethasone—psoriatic arthritis	0.000212	0.00251	CcSEcCtD
Neostigmine—Rash—Betamethasone—psoriatic arthritis	0.000212	0.00251	CcSEcCtD
Neostigmine—Dermatitis—Betamethasone—psoriatic arthritis	0.000212	0.00251	CcSEcCtD
Neostigmine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000212	0.00251	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000211	0.00251	CcSEcCtD
Neostigmine—Headache—Dexamethasone—psoriatic arthritis	0.000211	0.0025	CcSEcCtD
Neostigmine—Headache—Betamethasone—psoriatic arthritis	0.000211	0.0025	CcSEcCtD
Neostigmine—Asthenia—Prednisone—psoriatic arthritis	0.00021	0.00249	CcSEcCtD
Neostigmine—Pruritus—Prednisone—psoriatic arthritis	0.000207	0.00246	CcSEcCtD
Neostigmine—Diarrhoea—Prednisone—psoriatic arthritis	0.000201	0.00238	CcSEcCtD
Neostigmine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.0002	0.00237	CcSEcCtD
Neostigmine—Nausea—Dexamethasone—psoriatic arthritis	0.0002	0.00237	CcSEcCtD
Neostigmine—Nausea—Betamethasone—psoriatic arthritis	0.0002	0.00237	CcSEcCtD
Neostigmine—Urticaria—Methotrexate—psoriatic arthritis	0.000195	0.00231	CcSEcCtD
Neostigmine—Dizziness—Prednisone—psoriatic arthritis	0.000194	0.0023	CcSEcCtD
Neostigmine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000194	0.00229	CcSEcCtD
Neostigmine—Vomiting—Prednisone—psoriatic arthritis	0.000186	0.00221	CcSEcCtD
Neostigmine—Rash—Prednisone—psoriatic arthritis	0.000185	0.00219	CcSEcCtD
Neostigmine—Dermatitis—Prednisone—psoriatic arthritis	0.000185	0.00219	CcSEcCtD
Neostigmine—Headache—Prednisone—psoriatic arthritis	0.000184	0.00218	CcSEcCtD
Neostigmine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00018	0.00214	CcSEcCtD
Neostigmine—Asthenia—Methotrexate—psoriatic arthritis	0.000176	0.00208	CcSEcCtD
Neostigmine—Nausea—Prednisone—psoriatic arthritis	0.000174	0.00206	CcSEcCtD
Neostigmine—Pruritus—Methotrexate—psoriatic arthritis	0.000173	0.00205	CcSEcCtD
Neostigmine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000168	0.00199	CcSEcCtD
Neostigmine—Dizziness—Methotrexate—psoriatic arthritis	0.000162	0.00192	CcSEcCtD
Neostigmine—Vomiting—Methotrexate—psoriatic arthritis	0.000156	0.00185	CcSEcCtD
Neostigmine—Rash—Methotrexate—psoriatic arthritis	0.000154	0.00183	CcSEcCtD
Neostigmine—Dermatitis—Methotrexate—psoriatic arthritis	0.000154	0.00183	CcSEcCtD
Neostigmine—Headache—Methotrexate—psoriatic arthritis	0.000153	0.00182	CcSEcCtD
Neostigmine—Nausea—Methotrexate—psoriatic arthritis	0.000146	0.00172	CcSEcCtD
